Literature DB >> 16703493

[Imaging of enthesitis: a new field for the radiologist?].

K-G A Hermann1, I Eshed, M Bollow.   

Abstract

Entheses are sites where tendons, ligaments, joint capsules, or fasciae attach to bone. Their function is to provide a mechanism for reducing stress at the bony interface by dissipating the biomechanical load acting on the bone. Enthesitis may occur in traumatic, endocrinologic, metabolic, degenerative, or inflammatory conditions and is a major symptom in patients with seronegative spondyloarthritis (SpA). The increasing interest in inflammation of the entheses associated with rheumatoid diseases has fundamentally changed our understanding of the clinical presentation, pathogenesis, and therapy of enthesitis. Conventional radiographs and computed tomography (CT) allow good evaluation of chronic changes of the entheses, such as soft-tissue calcification, erosions, and new bone formation. The method of first choice to evaluate acute enthesitis is magnetic resonance imaging (MRI), which depicts both soft-tissue changes and intraosseous abnormalities. The purpose of this overview is to discuss the MRI appearance of enthesitis in patients with SpA and to provide a morphologic survey of the predominantly affected entheses.

Entities:  

Mesh:

Year:  2006        PMID: 16703493     DOI: 10.1055/s-2006-926748

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  3 in total

Review 1.  [Ankylosing spondylitis--current state of imaging including scoring methods].

Authors:  C E Althoff; K G Hermann; J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

2.  Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis.

Authors:  C E Althoff; H Appel; M Rudwaleit; J Sieper; I Eshed; B Hamm; K-G A Hermann
Journal:  Ann Rheum Dis       Date:  2007-07       Impact factor: 19.103

Review 3.  [Typical arthritis of the hands : Psoriatic arthritis].

Authors:  Matthias Bollow
Journal:  Radiologe       Date:  2021-03-30       Impact factor: 0.635

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.